COWEN AND COMPANY, LLC 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:00 pm Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
COWEN AND COMPANY, LLC | 0 0.000% |
-3,732,778 (Position Closed) |
Filing |
| 2022-01-21 11:12 am Purchase |
2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
COWEN AND COMPANY, LLC | 3,732,778 6.370% |
691,154 (+22.72%) |
Filing |
| 2021-11-12 2:11 pm Purchase |
2021-11-09 | 13G | Avadel Pharmaceuticals plc AVDL |
COWEN AND COMPANY, LLC | 3,041,624 5.180% |
3,041,624 (New Position) |
Filing |